The results have been consistently promising across multiple tissue types and organ systems, though large-scale human clinical trials remain limited
some participants also had type 2 diabetes
analyzed patients initially treated with GLP-1 RAs or SGLT2i, subsequently adding the second agent to evaluate the effects of combination therapy compared to monotherapy and differencing across groups (113, 114)
How Cagrilintide Works: The Science Behind the Peptide Cagrilintide acts on amylin receptors in the brain, primarily targeting the area postrema and nucleus tractus solitarius, both of which influence hunger and satiety signals
Trulicity Lawsuit Update 2026 Update July 1, 2026: MDL About Trulicity, Similar GLP-1 Drugs Grows by Over 80 Lawsuits As of July 1, 2026, 85 more lawsuits have joined the multidistrict litigation (MDL) against Eli Lilly (Trulicitys manufacturer) and other drug companies
We thank Daniel Drucker and Anthony Gramolini (Toronto, Canada) and Gary Lopaschuk (Edmonton, Canada) for helpful discussions and Daniel Drucker for providing the Glp1r / mice